Panagora Asset Management Inc Cyclerion Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$2.73 - $4.13 $3,802 - $5,753	-1,393 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$2.69 - $5.12 $1,100 - $2,094	-409 Reduced 22.7%	1,393 $4,000
Q4 2020 Feb 10, 2021	SELL	$2.25 - $7.12 $243 - $768	-108 Reduced 5.65%	1,802 $6,000
Q3 2020 Nov 13, 2020	BUY	$3.46 - $8.39 $6,608 - $16,024	1,910 New	1,910 $12,000
Q2 2020 Aug 12, 2020	SELL	$2.37 - $7.14 $49 - $149	-21 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$2.46 - $5.84 $573,610 - $1.36 Million	-233,175 Reduced 99.99%	21 $0
Q4 2019 Feb 12, 2020	SELL	$1.8 - $13.43 $2,980 - $22,240	-1,656 Reduced 0.71%	233,196 $634,000
Q3 2019 Nov 12, 2019	BUY	$8.12 - $14.54 $528,855 - $946,990	65,130 Added 38.37%	234,852 $2.85 Million
Q2 2019 Aug 09, 2019	BUY	$9.6 - $22.85 $1.63 Million - $3.88 Million	169,722 New	169,722 $1.94 Million

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $139M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.